US 7915240
Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
granted A61KA61K31/16A61K31/221
Quick answer
US patent 7915240 (Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines) held by OM PHARMA expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OM PHARMA
- Grant date
- Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/16, A61K31/221, A61K31/661, A61K31/6615